Global Osteosynthesis Implants Market Overview
Osteosynthesis Implants Market size was valued at USD 5.40 Billion in 2023. The Osteosynthesis Implants Market is projected to grow from USD 5.67 Billion in 2024 to USD 9.66 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.11% during the forecast period (2024 - 2032).
Rising incidences of osteoporosis across the globe and an increasing incidence of fractures are the major factors driving the growth of the global osteosynthesis implant market. However, the complications associated with osteosynthesis implants are expected to restrain the growth of the global market. Nevertheless, growing technological advancements, ongoing clinical trials, and an increasing elderly population worldwide are anticipated to create lucrative opportunities for the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Osteosynthesis Implants Trends
-
Rising incidences of osteoporosis across the globe
Osteoporosis, characterized by decreased bone density and increased fragility, poses significant challenges in the context of fracture management. Individuals with osteoporosis are at a higher risk of sustaining fractures, particularly in weight-bearing bones such as the hip, spine, and wrist. When fractures occur in osteoporotic bones, they often present unique challenges due to compromised bone quality and reduced mechanical stability. Osteosynthesis implants play a crucial role in the treatment of fractures in osteoporotic patients by providing mechanical support and facilitating fracture healing.
The increasing incidences of osteoporosis across the globe is increasing the demand for osteosynthesis implants. For instance, in 2019, the International Osteoporosis Foundation reported that every three seconds, a person in the world fractures a bone due to osteoporosis, and approximately 500 million men and women may be affected by osteoporosis across the globe.
Osteosynthesis Implants Segment Insights
Osteosynthesis Implants Product Insights
The global osteosynthesis implants’ segmentation, based on product, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices. The screws and plates segment accounted for the largest market share in 2022 due to increasing incidence of bone fractures and increasing surgical procedures.
Osteosynthesis Implants Axis Type Insights
The osteosynthesis implants market segmentation, based on material, includes stainless steel, titanium and titanium alloys, bioabsorbable polymers, and others. The stainless-steel segment held the largest market share in 2022 and titanium and titanium alloys fastest growing segment during the forecast period i.e., 2024 -2032. increasing demand of corrosion resistance materials, and titanium alloys meets regulatory compliance and standards are some of the factors driving the market.
Figure 2: Osteosynthesis Implants Market, by axis type, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Osteosynthesis Implants Fracture Type Insights
The Osteosynthesis Implants Market has been segmented, based on fracture type into hip fracture, knee fracture, spine fracture, shoulder fracture, and others. Hip fracture has the largest market share in 2022 due to the increasing prevalence of osteoporosis which leads to cause of hip fractures.
Osteosynthesis Implants End User insights
The Osteosynthesis Implants Market has been segmented, based on end user into hospitals, orthopedic clinics, and ambulatory surgical centers. Hospitals have the largest market share in 2022 due to the collaboration among hospitals, orthopedic manufacturers, and research institutions drives innovation and market growth.
Osteosynthesis Implants Region Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America Osteosynthesis Implants accounted for the largest market share of 39.76% in 2022 and is anticipated to reach approximately USD 3.98 billion by 2032 at a 6.33% CAGR during the forecast period. However, Europe is projected to grow at the highest CAGR of 7.35% during the forecast period.
The outlook for the North America Osteosynthesis Implants market remains promising, with sustained growth anticipated. High incidence of trauma and sports injuries, Rise in the number of orthopedic surgeries, and Excellent healthcare infrastructure and facilities the osteosynthesis implants market.
The Europe Osteosynthesis Implants’ market is currently undergoing substantial growth, driven by a confluence of factors that include rising prevalence of osteoporosis, rising sports injuries, and increasing patient awareness about the benefits of surgical intervention contributes to the growth of the osteosynthesis market.
Further, the major countries will be study are US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: Osteosynthesis Implants Market By Region 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Asia-pacific Osteosynthesis Implants market accounted for USD 0.99 billion in 2022 and is projected to grow at a CAGR of 5.13% during the forecast period. Asia-Pacific is further segmented into the China, India, Japan, South Korea, Australia, and Rest of Asia-Pacific. Additionally, the increasing healthcare infrastructure in developing countries, and rapid population growth, further contributes to the market expansion.
The Rest of the World Osteosynthesis Implants market accounted for USD 0.71 Billion in 2022 and is projected to grow at a CAGR of 2.76% during the forecast period. Rest of the World is further segmented into the Middle East, Africa & Latin America.
Osteosynthesis Implants Key Market Players & Competitive Insights
The Osteosynthesis Implants Market is distinguished by the presence of many global, regional, and local players. Rising incidences of osteoporosis across the globe and an increasing incidence of fractures are the major factors driving the growth of the global osteosynthesis implant market. However, the complications associated with osteosynthesis implants are expected to restrain the growth of the global market. Nevertheless, growing technological advancements, ongoing clinical trials, and an increasing elderly population worldwide are anticipated to create lucrative opportunities for the market. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their devices and signing contracts and agreements to broaden their reach and reduce operational costs. The Osteosynthesis Implants Market is extremely competitive, with players competing, partnering, and investing heavily in R&D to gain a significant market share. The market is moderately fragmented with rising competition, product launches, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.
Braun SE is a healthcare manufacturer and supplier and offers its products to hospitals, surgical units, private practices (medical care and doctors' offices), and extracorporeal blood treatments. Its key business areas include clinical nutrition, urinary care, infection prevention, infusion therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopedics, spine care, and wound care. The company operates through three major business segments: hospital care, Aesculap, and B. Braun Avitum. It offers approximately 5,000 products through the above-mentioned business, out of which it manufactures 95% of the products. It has operations across 64 countries in all regions, namely the Americas, Europe, Asia-Pacific, and the Middle East & Africa. It operates through its various subsidiaries, such as B. Braun Medical Inc. (Germany), Aesculap AG (Germany), and B. Braun Avitum France SAS (France), to expand its geographic reach.
Furthermore, in September 2023, Arthrex, Inc. received FDA Clearance for TightRope Implant as first, only device cleared for pediatric ACL surgery.
Key Companies Osteosynthesis Implants in market includes.
- Medartis AG
- Dieter Marquardt Medizintechnik GmbH
- Lepu Medical Technology(Beijing)Co.,Ltd.
- Globus Medical, Inc
- Zimmer Biomet
- Arthrex, Inc.
- Precision Spine, Inc
- Johnson & Johnson Services, Inc
- CONMED Corporation
- Braun SE
Osteosynthesis Implants Industry Developments
- July 2023, Globus Medical, Inc. announced the launch of the MARVEL Growing Rod System for paediatric patients with early onset scoliosis. The system uses minimally invasive distraction to provide correction and promote growth.
- October 2021, Globus Medical, Inc. announced the launch of its new ANTHEM Mini Fragment Fracture System at the annual Orthopaedic Trauma Association (OTA) meeting.
- June 2021, Johnson & Johnson, a healthcare company announced the launch of 2.7 mm Variable Angle Locking Compression Plate (VA LCP) Clavicle Plate System for the treatment of lateral, shaft and medial fractures for small, medium, and large clavicles. This new system offers plate shapes that reflect the correlation between patient stature and clavicle size to match the bow and contour of the clavicle and accommodate a broad range of anatomic variability of the clavicle.
Osteosynthesis Implants Market Segmentation:
Osteosynthesis Implants Product Outlook
- Screws and Plates
- Wires and Pins
- Intramedullary Rods and Nails
- Spinal Fixation Devices
Osteosynthesis Implants Material Outlook
- Stainless Steel
- Titanium and Titanium Alloys
- Bioabsorbable Polymers
- Others
Osteosynthesis Implants Fracture Type Outlook
- Hip Fracture
- Knee Fracture
- Spine Fracture
- Shoulder Fracture
- Others
Osteosynthesis Implants End user Outlook
- Hospitals
- Orthopaedic Clinics
- Ambulatory surgical Centers
Osteosynthesis Implants Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 5.40 Billion |
Market Size 2024 |
USD 5.67 Billion |
Market Size 2032 |
USD 9.66 Billion |
Compound Annual Growth Rate (CAGR) |
6.11% (2024-2032) |
Base Year |
2023 |
Forecast Period |
2024-2032 |
Historical Data |
2019 to 2022 |
Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product, Material, Fracture Type, End Users, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered |
The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
·      Medartis AG ·      Dieter Marquardt Medizintechnik GmbH ·      Lepu Medical Technology(Beijing)Co.,Ltd. ·      Globus Medical, Inc ·      Zimmer Biomet ·      Arthrex, Inc. ·      Precision Spine, Inc ·      Johnson & Johnson Services, Inc ·      CONMED Corporation ·      B.Braun SE |
Key Market Opportunities |
·      Growing technological advancements ·      Ongoing clinical trials ·      Increasing elderly population worldwide |
Key Market Drivers |
·      Rising incidences of osteoporosis across the globe ·      Increasing incidence of fractures |
Frequently Asked Questions (FAQ) :
The Osteosynthesis Implants Market is anticipated to reach 9.66 billion by 2032.
The US is expected to hold 76.54% share of the North America market.
The Osteosynthesis Implants market is expected to grow at a 6.11% CAGR during the forecast period from 2024 to 2032.
The North America region market is estimated to hold the largest market share in the Osteosynthesis Implants ‘s market.
Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology(Beijing)Co.,Ltd., Globus Medical, Inc, Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc, Johnson & Johnson Services, Inc, CONMED Corporation, and B.Braun SE.